Medlab West Africa is part of the Informa Markets Division of Informa PLC


Co-located with:

Why visit Medlab West Africa?

Discover unparalleled opportunities and breakthroughs in laboratory industry

Connect with exhibitors from over 30+ countries, explore cutting-edge lab-tech products and seize diverse opportunities—all under one roof.

2024 Partners


A world leader in the field of in vitro diagnostics for 60 years, bioMérieux is present in 45 countries and serves more than 160 countries through a large network of distributors. bioMérieux provides diagnostic solutions (systems, reagents, software and services) that determine the origin of a disease to improve the health of patients. World leader in microbiology, specialized in immunoassays and leading pioneer in the syndromic molecular approach, the Company is committed worldwide on major public health issues in the field of infectious diseases, such as antimicrobial resistance, sepsis and respiratory infections. 

Crown Healthcare

Crown Healthcare is a pioneering force in the African medical equipment industry, renowned for our commitment to innovation and excellence. Specializing in the procurement, installation, and maintenance of top-quality medical devices and reagents, we cater to the diverse needs of healthcare facilities across Nigeria, the West African region, and beyond. With a steadfast presence in five African countries and a dedicated team of over 500 professionals, we deliver unparalleled service and support. Representing world-class brands such as Karl Storz, Mindray, United Imaging, GE, Wondfo, Nefro, Laborex, DRGem, Aeonmed, Sonoscape,Acon, SECA, 3M. We offer superior products at competitive prices, ensuring that our clients receive exceptional value and reliability. At Crown Healthcare, we are your trusted partner for comprehensive medical solutions.


DCL Laboratory Products Ltd is the leading provider of medical laboratory solutions with Headquarter in Nigeria and other regional offices in Ghana, Liberia, Sierra Leone, Gambia etc. Founded in 2005 with ISO 9001:2015 accreditation, DCL provides end to end solutions in the areas of Clinical Chemistry, Hematology, Histopathology, New Borne Screening, HID, Blood banking, Molecular pathology, Microbiology, PGD, Forensic medicine. Driving its values through quality and sustainable laboratory solutions across laboratory spaces and enhancement of social values through CSR, DCL partners with over 50 world acclaimed manufacturers of IVDs helping to enhance outcome of quality healthcare in Nigeria. DCL staff comprise highly motivated men and women reflecting true diversity which DCL now harnesses as one of her key internal strengths.


Founded in 1995, Snibe is a global leading in-vitro diagnostic solution provider who has focused on the chemiluminescence immunoassay (CLIA) field for more than 28 years and also become the first CLIA manufacturer in China to get FDA-cleared. At present, we have provided customized diagnostic solutions to laboratories in more than 153 countries and regions. Over 30000 units of Snibe's products have reached worldwide, including global chain labs and hospitals like Synlab, Eurofins, Cerba, Synevo, etc.

Snibe established 4 core R&D centers, including reagent, instrument, magnetic microbead, and reagent raw material to lay a solid foundation for developing the broadest range of CLIA analyzers and a relevant test menu with more than 200 parameters. Under strong technical support, we successfully launched one of the fastest CLIA analyzer in the world - MAGLUMI X8 with a throughput of 600T/H in 2018; In order to meet the demand of mega-laboratories, Snibe announced a strategic partnership with Thermofisher and Hitachi to launch the Total Laboratory Automation solution in 2019; Moreover, to help fight against COVID-19, Snibe successfully developed the 2019-nCoV (SARS-CoV-2) CLIA Kits in 2020, the first of its kind in the world to receive the CE mark.

"Creating value for human health through continuous innovation" is our mission. Snibe's striving for excellence never ends.


QIAGEN is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics). As of December 31 2021, QIAGEN employed more than 6,000 people in over 35 locations worldwide.


Molbio Diagnostics, a pioneer in the healthcare industry, is dedicated to transforming global healthcare by delivering precise, rapid, and cost-effective diagnoses at the Point of Care (POC). Molbio’s vision is rooted in ensuring universal access to cutting-edge healthcare technologies by addressing the evolving needs of patients and decentralizing and democratizing diagnostics through advanced portable platforms. Renowned for its WHO-endorsed "Truenat" real-time PCR platform, Molbio enables remote healthcare settings globally to implement sophisticated molecular diagnostics for diseases such as TB, hepatitis, HPV, HIV, COVID-19, Dengue, and more. Molbio is strategically expanding its impact through collaborations with innovators, introducing new-age point-of-care technologies to address diverse health challenges, including non-communicable diseases such as breast cancer, sickle cell disease, diabetes and more. Molbio's steadfast commitment to disease elimination is evident in its creation of advanced solutions for quality healthcare at the last mile, establishing its role as a leader in shaping a healthier world.